| Application no. and date | 12735991.7 (espacenet) (Federated) (European Patent Register), 20120628 | | Patent/reg. no. and date | DK/EP 2726508, 20170809 | | Publication date | 20140507 | | Priority no. and date | US 201161502167 P, 20110628, WO PCT/US2012/044451, 20120627 | | EP pub. no. and date |
EP 2726508 20140507 | | Effective date | | | Applicant/owner | Oxford BioTherapeutics Ltd, 94A Innovation Drive
Milton Park
Abingdon
Oxfordshire OX14 4RZ, GB | | Applicant ref. no. | V1708-022-DK | | Inventor | ROHLFF, Christian, Oxford Bio Therapeutics Ltd.
94A Milton Park
Abington
Oxon OX14 4RY, GB,
TERRETT, Jonathan, Alexander, 5941 Optical Court
San Jose, CA 95138, US | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | C07K 16/28 (2006.01) | | Title | ANTISTOFFER MOD ADP-RIBOSYL-CYCLASE-2 | | Int. application no. | US2012044703 | | Int. publication no. | WO2013003625 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
